Radio Havana Cuba

A friendly voice around the world

  • Follow Us on

#NoMasBloqueo #SolidaridadVsBloqueo

Clinical Trial Begins in U.S. for Cuban Lung Cancer Vaccine

New York, January 7 (RHC-Agencies)-- Roswell Park Cancer Institute in Buffalo, New York, has launched the first clinical trial in the United States to study the CIMAvax-EGF vaccine, a lung cancer treatment that was developed in Cuba. Roswell Park is then the only facility in the United States that offers this groundbreaking treatment.

CIMAvax-EGF vaccine is a lung cancer treatment that was developed by researchers with the Havana-based Molecular Immunology Center. The medication is a type of therapy that harnesses the body’s immune system to fight lung cancer.

The current trial is a Phase I out of II study of the CIMAvax-EGF vaccine in combination with the Anti-PD1 checkpoint inhibitor nivolumab in patients previously treated for advanced non-small cell lung cancer (NSCLC).

Edited by Pavel Jacomino
Commentaries
MAKE A COMMENT
  • RHC's Arts Roundup
  • Cuba ratifies its unwavering support for Nicaragua
  • Cuba renews its solidarity with Nicaragua
  • RHC's Caribbean Outlook Show
  • Cuban lawmakers studying draft of new Constitution
  • Machado Ventura: Unity among the left and progressive forces is urgently needed these days
NUMBER OF HITS/VISITORS

4949078

  • Max: 19729
  • yesterday: 3453
  • today: 2781
  • online: 96
  • total: 4949078